March 11, 2026
1 min read

Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China

The $3 billion investment will take shape over the next ten years, the company said, and will increase the global supply of its oral GLP-1 prospect orforglipron.

Leave a Reply

Your email address will not be published.

Previous Story

LabelBlind: India’s packaged foods hit by nutrition label noncompliance amid sector boom

Next Story

Red states hit hardest by reduced NIH funding

Previous Story

LabelBlind: India’s packaged foods hit by nutrition label noncompliance amid sector boom

Next Story

Red states hit hardest by reduced NIH funding

Latest from Blog

Go toTop